Antiphospholipid Syndrome Patients’ Monocytes Are “Primed” to Express Tissue Factor

Frances M. K. Williams; Karen Jurd; Graham R. V. Hughes; Beverley J. Hunt

doi:10.1055/s-0037-1615376

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1998; 80(05): 864-865
DOI: 10.1055/s-0037-1615376

Letters to the Editor

Schattauer GmbH

Antiphospholipid Syndrome Patients’ Monocytes Are “Primed” to Express Tissue Factor

Frances M. K. Williams

¹From the Lupus Research Unit and Department of Haematology, St. Thomas’ Hospital, London, UK

,

Karen Jurd

¹From the Lupus Research Unit and Department of Haematology, St. Thomas’ Hospital, London, UK

,

Graham R. V. Hughes

¹From the Lupus Research Unit and Department of Haematology, St. Thomas’ Hospital, London, UK

,

Beverley J. Hunt

¹From the Lupus Research Unit and Department of Haematology, St. Thomas’ Hospital, London, UK

› Author Affiliations

Abstract

Full Text

References

References
1 Arnout J. The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb Haemost 1996; 75 (Suppl. 04) 536-41.
2 Esmon NL, Smirnov MD, Esmon CT. Thrombogenic mechanisms of anti-phospholipid antibodies. Thromb Haemost 1998; 78 (Suppl. 01) 79-82.
3 Roubey RAS, Hoffman M. From antiphospholipid syndrome to antibody-mediated thrombosis. Lancet 1998; 350: 1491-3.
4 Osterud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost 1983; 49 (Suppl. 01) 5-7.
5 Leatham EW, P.M.W. B Tooze JA, Camm AJ. Increased monocyte tissue factor expression in coronary disease. Br Heart J 1995; 73: 10-3.
6 Semeraro N, Montemurro P, Giordano P, Santoro N, De Mattia D, Colucci M. Increased mononuclear cell tissue factor and type 2 plasminogen activator inhibitor and reduced plasma fibrinolytic capacity in children with lymphoma. Thromb Haemost 1994; 72: 54-7.
7 Rosendaal FR. Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis. Thromb Haemost 1998; 78 (Suppl. 01) 1-6.
8 Amengual O, Atsumi T, Khamashta MA, Hughes GRV. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost 1998; 79: 271-81.
9 Altieri DC, Morrissey JH, Edgington TS. Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade. Proc Natl Acad Sci USA 1988; 85: 7462-6.
10 Parratt R, Hunt BJ. Direct activation of factor X by monocytes occurs during cardiopulmonary bypass. Brit J Haematol 1998; 101: 43-6.
11 Schved J-F, Gris J-C, Ollivier V, Wautier J-L, Tobelem G, Caen J. Procoagulant activity of endotoxin or tumour necrosis factor activated monocytes is enhanced by IgG from patients with lupus anticoagulant. Am J Hematol 1992; 41: 92-6.
12 Reverter J-C, Tassies D, Font J. et al. Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein S. Arterioscler Thromb Vasc Biol 1996; 16 (11) 1319-26.
13 Kornberg A, Blank M, Kaufman S, Shoenfeld Y. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol 1994; 153: 1328-32.
14 Cuadrado MJ, Lopez-Pedrera C, Khamashta MA. et al. Thrombosis in primary antiphospholipid syndrome. Arthritis Rheum 1998; 40 (Suppl. 05) 834-41.
15 van den Eijinden MM, Steenhauer SI, Reitsma PH, Bertina RM. Tissue Factor expression during monocyte-macrophage differentiation. Thromb Haemost 1998; 77 (Suppl. 06) 1129-36.
16 Mackman N. Regulation of the tissue factor gene. Thromb Haemost 1998; 78 (Suppl. 01) 747-54.
17 Rodriquez-Linares B, Watson SP. Thrombopoietin potentiates activation of human platelets in association with JAK2 and TYK2 phosphorylation. Biochem J 1996; 316 (Suppl. 01) 93-8.